Log In
Print this Print this

Dengue antiviral

  Manage Alerts
Collapse Summary General Information
Company Siga Technologies Inc.
DescriptionOrally bioavailable antiviral dengue fever compound
Molecular Target
Mechanism of ActionAntiviral agent
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPreclinical
Standard IndicationDengue fever
Indication DetailsTreat dengue fever
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today